Tennis legend Serena Williams is the first active pro athlete to confirm she's competing while taking a GLP-1 medication for ...

DR. RAYMOND LAU: ‘Guidance has evolved as we’ve gained more experience with these medications.’ GLP-1 therapies may no longer be considered “new,” but that doesn’t mean the fervor has died down.

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from ...

Popular GLP-1 weight-loss drugs are becoming much more affordable for millions of older adults starting Wednesday, July 1, as Medicare begins to cover them — for now. The Medicare GLP-1 Bridge is a ...

Before Serena Williams picked up her racket at London’s Andy Murray Arena last week, two questions hung over her return to tennis. First: How would she do? She answered that, in her first competition ...

Samantha had enjoyed her weekend cooking ritual for years. Four months into Zepbound (a popular GLP-1 medicine), however, something changed. She stood in her kitchen on a Saturday morning and made the ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Novo Nordisk, the maker of Wegovy, introduced its GLP-1 pill for weight loss in early January ...

Anti-fat jabs are throwing fashion a new curve. A staggering $5 billion in clothing inventory is at risk of going to waste thanks to fashionistas melting away their waists on GLP-1 drugs, per alarming ...

A wave of new research is expanding what clinicians and health system leaders know about GLP-1 medications — covering new territory from liver disease to male fertility to a blood pressure safety ...